Vol. 7 (08) pp. 337-343 DOI: 10.21474/IJAR01/9510

EXPLORING BIOMARKERS OF ANEMIA IN NEONATES WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.

  • Non-Communicable Diseases and Cancer Research Unit, Laboratory of Applied Biology Research, EcolePolytechniqued?Abomey-Calavi, University of Abomey-Calavi, Benin, 01BP 2009 Cotonou, B?nin.
  • Medical Genetics and Neonatology, "Centre National Hospitalier et Universitaire H.K. Maga", 01BP 386, Cotonou, Benin.
  • Laboratory of Molecular Genetics and Genome Analyzes, Faculty of Sciences and Technics, University of Abomey-Calavi, 01BP 526, Cotonou, Benin.
29 Downloads 182 Views
Crossref

Abstract

Background: Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common enzymopathy. It induces haemolytic crises with hyperbilirubinemia in newborns and a consequent anemia. Objective: In this study, we aimed to assess if anemia markers are affected in G6PD deficient newborn in the absence of oxidative attack. Methods: This is a cross-sectional descriptive study carried on in 185 infants aged 7 days and younger in southern Benin. The enzymatic activity of G6PD was assayed with Lactate Dehydrogenase (LDH) and Alkaline Phosphatase ALP) activities, Iron, Total Proteins (TP), reticulocytes levels and hemoglobin (Hb) levels. Data were analyzed with SigmaPlot Statistical Analysis Software 2014. Mean and Standard Errors on the Mean (SEM) of blood parameters were calculated. Student's t-test and Mann-Whitney Rank Sum test were used to ascertain difference between group characteristics. The study was approved by the national ethics committee. Results: A total of 44 newborns (23.78%) were G6PD deficient. The Minan and Adja ethnic groups were the most affected with a prevalence of 45.45% and 40.00% respectively. The mean level of TP (57.92?2.04 vs. 61.31?5.01), Iron (1.78?0.15 vs. 1.76?0.44) and the enzymatic activity level of PAL (136.76?6.69 vs. 117.33?5.04) and LDH (291.15?19.50 vs. 279.57?69.32) did not vary significantly in severe G6PD deficientneonates compared to normal. Conclusion: Hemolytic anemia biomarker are not affected in G6PD deficiency neonates.

Keywords

How to Cite This Article

Salomon E. M. Fiogbe, Casimir D. Akpovi, Julien G.A. Segbo, Fifame E.E. Kougnimon, Edgard Romeo S. Tcheoubi, Gratien G. Sagbo and Clement Agbangla. (2019); EXPLORING BIOMARKERS OF ANEMIA IN NEONATES WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY., International Journal of Advanced Research (IJAR), 7 (08), 337-343, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/9510

Corresponding Author

Casimir D. AKPOVI
Research Laboratory in Applied Biology, Ecole Polytechnique d’Abomey-Calavi, University of Abomey-Calavi, Benin,

Article Analytics

References

  1. Adedemy, J.D., Gomina, M., Agossou, J., Noudamadjo, A., Mouna, E., d?Almeida, M. and Adeothy-Koumakpa?, S. (2015): Prevalence of glucose 6 phosphate dehydrogenase deficiency among infants and children of Parakou, Benin. Curr. Pediatr. Res., 19(2): 58-65.
  2. Ahmed, S., Saleem, M., Modell, B. and Petrou, M. (2002): Screening extended families for genetic hemoglobin disorders in Pakistan. N. Engl. J. Med., 347: 1162-1168.
  3. Al-Sweedan, S.A., Jdaitawi, H., Khriesat, W.M., Khader, Y.Y. and Al-Rimawi, H.S., (2009): Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses. Hematol. Oncol. Stem. Cell. Ther., 2(2): 354-357.
  4. Beard, J.L. (2001): Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr., 131: 568-580
  5. Bittles, A. (2001): Consanguinity and its relevance to clinical genetics. Clin. Genet., 60: 89-98.
  6. Cappellini, M.D. and Fiorelli, G. (2008): Glucose-6-phosphate dehydrogenase deficiency. Lancet, 371: 64-74.
  7. Doxiadis, S.A. and Valaes, T. (1964): The Clinical Picture of Glucose-6-Phosphate Dehydrogenase Deficiency in Early Infancy. Arch. Dis. Child., 39: 545-553.
  8. Drousiotou, A., Touma, E.H., Andreou, N., Loiselet, J., Angastiniotis, M., Verrelli, B.C. and Tishkoff, S.A. (2004): Molecular characterization of G6PD deficiency in Cyprus. Blood Cells. Mol. Dis., 33: 25-30.
  9. El-Mauhoub, M., Parida, S.N., Kishan, J., Soni, A.L. and Nagarajan, S. (1989): Cutaneous erythropoiesis: an unusual manifestation of Rh hemolytic disease. Indian J. Pediatr., 56: 411-413.
  10. Emerson, P.M. and Wilkinson, J.H. (1966): Lactate Dehydrogenase in the Diagnosis and Assessment of Response to Treatment of Megaloblastic Anaemia. Br. J. Haematol., 12(6): 678-688.
  11. Fiogbe, S.E.M., Akpovi, C.D., S?gbo, J.A.G., Bognon, G., Medehouenou, M.T.C., Sagbo, G.G. and Agbangla, C. (2018): Liver function assessment in Glucose-6-Phosphate Dehydrogenase deficient neonates in Benin. Int. J. Biomed. Res., 09(06): 221-225.
  12. Gaikwad, A.L. and Jadhav, D.S. (2018): Utility of serum lactate dehydrogenase in the diagnosis of megaloblastic anemia. Int. J. Res. Med. Sci., 6(9):3051-3056
  13. Gronvall, C. (1961): On the serum activity of lactic acid dehydrogenase and phosphohexoseisomerase in pernicious and hemolytic anemias. Scand. J. Clin. Lab. Invest., 13: 29-36.
  14. Hamid, M.M.A., Albsheer, M., Muneer, M., Altinae, L. and Lover, A.A. (2019): Prevalence and risk factors for glucose-6-phosphate dehydrogenase (g6pd) deficiency in two P. vivax malaria-endemic areas in Sudan. BMJ Glob. Health, 4: 62-72.
  15. Howes, R.E., Battle, K.E., Satyagraha, A.W., Baird, J.K. and Hay, S.I. (2013): G6PD Deficiency, in Advances in Parasitology. Elsevier, pp. 133-201.
  16. Mehta, A., Mason, P.J. and Vulliamy, T.J. (2000): Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract. Res. Clin. Haematol., 13: 21-38.
  17. Nalbantoğlu, A., Ovalı, F. and Nalbantoğlu, B. (2011): Alkaline phosphatase as an early marker of hemolysis in newborns: Alkaline phosphatase in hemolysis. Pediatr. Int., 53: 936-938.
  18. Noori-Daloii, M.R., Hajebrahimi, Z., Najafi, L., Mesbah-Namin, S.A., Mowjoodi, A., Mohammad Ganji, S., Yekaninejad, M.S. and Sanati, M.H. (2007): A comprehensive study on the major mutations in glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in the coastal provinces of Caspian Sea in the north of Iran. Clin. Biochem., 40: 699-704.
  19. Orimadegun, A.E. and Sodeinde, O. (2011): Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children. J. Infect. Dev. Ctries., 5(11): 792-798.
  20. Ruwende, C. and Hill, A. (1998): Glucose-6-phosphate dehydrogenase deficiency and malaria. J. Mol. Med. Berl. Ger., 76: 581-588.
  21. Sharma, M., Dass, J., Dhingra, B. and Saxena, R. (2011): G6PD deficiency in females screened at tertiary care hospital. Indian J. Pathol. Microbiol., 54: 850-851.
  22. Siimes, M.A., Addiego, J.E. and Dallman, P.R. (1974): Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood, 43: 581-590.
  23. Simpore, J., Ilboudo, D., Damintoti, K., Sawadogo, L., Maria, E. and Binet, S. (2007): Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease in Burkina Faso. Pakistan J. Bio. Sci., 10(3): 409-414
  24. Stadem, P.S., Hilgers, M.V., Bengo, D., Cusick, S.E., Ndidde, S., Slusher, T.M. and Lund, T.C. (2017): Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns. PloS One, 12(2): e0172980
  25. van den Broek, L., Heylen, E. and van den Akker, M. (2016): Glucose‐6‐phosphate dehydrogenase deficiency: not exclusively in males. Clin. Case Rep., 4(12): 1135-1137.
  26. WHO Working Group. (1989): Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ, 67: 601-611.
  27. Wickramasinghe, S.N. (2006): Diagnosis of megaloblasticanaemias. Blood Rev., 20: 299-318.
  28. Williams, O., Gbadero, D., Edowhorhu, G., Brearley, A., Slusher, T. and Lund, T.C. (2013): Glucose-6-phosphate dehydrogenase deficiency in Nigerian Children. PLoS ONE, 8(7): e68800.
  29. Ylmaz, S., Duman, N., ?zer, Esra, Kavas, N., ?ren, H., Demircioglu, F., Kumral, A., ?zkan, H., Irken, G. and ?zer, E. (2006): A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions: J. Pediatr. Hematol. Oncol., 28: 290-292.

Similar Articles